2019-06-08
Tumor Synoptic Report: Esophagus (Resection Specimen)
 (View Note) For esophagectomy and gastroesphagectomy specimens with carcinom, and adenocarcinom within 5 cm from G-E junction

 (Useful tips here ... before you start) -- Select item from a dropdown list, or click on checkbox.
-- Skip undesired items (they'll be removed from final report).
-- Point mouse at "View Note" to reveal more information.

Specimen and Surgical Procedure
Specimen Type:
 (View Note) -- Select from the dropdown list.
-- If the item is not listed, then select "Other (specify)" in the dropdown list and manually type it in "Specify Other" field.
(specify other)
Surgical Procedure: (specify other)

Tumor Histologic Characteristics
Tumor Histologic Type: (specify other)
Tumor Grade:
Tumor Site:
 (View Note) -- Select all that apply by clicking on the leading box(s).
-- Skip, if not applicable, to exclude from final report
Tumor Size: cm
Tumor Extension:
Tumor Budding:
 (View Note) Definitions:
-- Tumor buds: detached clusters of 1 - 5 tumor cells lacking gland lumen formation at the advancing edge of the tumor.
-- Budding field: field at 20x (= 0.765 sq mm)
See the reference below by Landau MS. et al.
Angiolymphatic Invasion:                      
Treatment Effect:
 (View Note) Treatment effect score schema:
-- Socre 0 (complete response) = No viable tumor cells.
-- Score 1 (near complete response) = Residual single tumor cells or rare small groups of tumor cells.
-- Score 2 (partial response) = Tumor regression but with residual tumor more than single cells or rare small groups of tumor cells.
-- Score 3 (poor or no response) = Extensive residual tumor with no evident tumor regression

Resection Margin Status:
The Closest Margin:
 (View Note) -- Manually enter (e.g. suture-marked edge, deep margin etc.)
        Distance from Tumor:  mm
Proximal Margin:
(Check all that apply)
Distal Margin:
(Check all that apply)
Radial Margin:
(Check all that apply)

Lymph Node (LN) Status:		                      
LN Number examined:
Number of LN involved:
Size of Largest Metastasis: cm
Extranodal Tumor Extension:                          

Ancillary Studies: 		                       
Test Ordered:
 (View Note) -- Check all that apply.   Scroll down for more options.

Pathologic Stage (AJCC 2018 ed.):

  Primary Tumor:

  Regional Lymph Node:

  Distant Metastasis:

Comments:

Key References (* denotes fully accessible and/or PDF downloadable on the Web):
1.* Haggitt RC. et al.: Recommendations for the reporting of resected esophageal carcinomas. Association of directors of anatomic and Surgical Pathology. Am J Clin Pathol (2000); 114(4):512-4.
2. Karamitopoulou E. et al: Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches. Am J Surg Pathol (2014); 38(11):1551-6.
3.* Landau MS. et al.: Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Modern Pathology (2014) 27: 1578–1589.
4.* Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer (2011) 14:101–112.



Disclaimer: This application tool is intended to facilitate pathology tumor-reporting process by web-based method.   The users are strongly referred to reputable information ressources and are expected to use their professional judgment as to the accuracy and adequacy of information presented in this web tool.   The owner of this site or its affiliated entities shall not be held liable for any adverse results from use or misuse of the reporting tool.